CBT intervention for opiate deprescribing- a qualitative evaluation V1

  • Research type

    Research Study

  • Full title

    The implementation of a manualised CBT informed intervention for opiate deprescribing within an NHS addiction service and patient feedback: A qualitative evaluation

  • IRAS ID

    331845

  • Contact name

    Laura Petley

  • Contact email

    l.petley@surrey.ac.uk

  • Sponsor organisation

    University of Surrey

  • Duration of Study in the UK

    0 years, 6 months, 7 days

  • Research summary

    Opiate substitution treatment (OST) is beneficial in reducing drug related harm for individuals using opiates. However, there are a number of barriers to deprescribing OST and the rates of deprescribing are low. Cognitive behavioural therapy (CBT) is an established psychological treatment which aims to change unhelpful thinking and behaviour, and hence improve an individual’s’ wellbeing. CBT has been shown to support and improve the outcomes of taper programs for opiates and other controlled medications, however this has yet to be evaluated in the context of tapering medication within addiction services. This approach is novel approach is being delivered by the clinical team at Aneurin Bevan Specialist Drug & Alcohol Service (ABSDAS). This research will examine staff perspectives on implementing this intervention, and patient perceptions of the intervention. This intervention will run regardless of whether individuals wish to partake in the research study. All service users who were offered the intervention will be invited to take part in the study. Data will be collected via qualitative feedback from service users and health care providers, via semi-structured interviewing. These findings will be used to establish the acceptability of a CBT intervention for OST tapering in this context, and the barriers and facilitators to implementing the intervention.

  • REC name

    East of England - Essex Research Ethics Committee

  • REC reference

    24/EE/0016

  • Date of REC Opinion

    19 Mar 2024

  • REC opinion

    Further Information Favourable Opinion